|04/17/15||BioMed Realty Trust to Report First Quarter 2015 Results|
|SAN DIEGO, April 17, 2015 (GLOBE NEWSWIRE) -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced it will report results for its first quarter ended March 31, 2015 after the market closes on Tuesday, April 28, 2015.
Alan D. Gold, Chairman, President and Chief Executive Officer, and other members of the BioMed Realty management team will host an investor conference call at 10:00 a.m. Pacific Time on Wednesday, April 29, 2015 to discuss the company's financial results and operations for the q... |
|04/15/15||BioMed Realty Launches Its 2014 Online Annual Report On Another Record-Breaking Year|
|Site Offers State-Of-The-Art Design and Navigation, Focused Digital Content and Easily Downloadable Information
SAN DIEGO, April 15, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that its 2014 Online Annual Report and other proxy materials are now available at http://www.biomedrealty.com/14AR.
Titled "The Next 10 Years," the 2014 Online Annual Report explores the company's outstanding results in 2014 and vision for 2015 and beyond. In addition, the site examin... |
|04/06/15||BioMed Realty Signs Alnylam Pharmaceuticals To 295,000 Square Foot Lease For Class A Laboratory And Office Space In Cambridge|
|RNAi Pioneer Taking Entire 675 West Kendall Laboratory and Office Building to Accommodate Growing R&D Efforts
CAMBRIDGE, Mass., April 6, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a 295,000 square foot lease at 675 West Kendall by Alnylam Pharmaceuticals in Cambridge, Massachusetts providing Alnylam with Class A laboratory and office space in the heart of Kendall Square.
Alnylam Pharmaceuticals is leading the translation of RNAi as a new c... |
|04/02/15||BioMed Realty Continues Leasing Momentum In Cambridge By Signing Biogen To 80,000 Square Feet|
|Biogen Expansion Pushes BioMed Realty's 301 Binney Property to 100 Percent Occupied
CAMBRIDGE, Mass., April 2, 2015 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) continues the strong leasing in March with the announcement of a new ten-year lease with Biogen for approximately 80,000 square feet of Class A laboratory and office space at the company's 301 Binney Street property in Cambridge, Massachusetts. Biogen develops, markets and manufactures therapies for people living with serious... |